{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:26:17Z","timestamp":1793910377965,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.fertnstert.2026.05.149","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:01:14Z","timestamp":1779084074000},"page":"237-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can a focus on intracellular signaling assist us with ovarian stimulation in poor-prognosis patients?"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1401-7722","authenticated-orcid":false,"given":"James P.","family":"Toner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Pirtea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"de Zieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2026.05.149_bib1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fendo.2019.00439","article-title":"Future perspectives of POSEIDON stratification for clinical practice and research","volume":"10","author":"Humaidan","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fendo.2019.00387","article-title":"Management of women with an unexpected low ovarian response to gonadotropin","volume":"10","author":"Conforti","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Pt B","key":"10.1016\/j.fertnstert.2026.05.149_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpobgyn.2022.05.003","article-title":"POSEIDON groups and their distinct reproductive outcomes: effectiveness and cost-effectiveness insights from real-world data research","volume":"85","author":"Esteves","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12958-024-01291-x","article-title":"Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria","volume":"22","author":"Alviggi","year":"2024","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5935\/1518-0557.20200100","article-title":"The POSEIDON stratification - moving from poor ovarian response to low prognosis","volume":"25","author":"Roque","year":"2021","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/352098","article-title":"Management of poor responders in IVF: is there anything new?","volume":"2014","author":"Ubaldi","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","article-title":"The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.mce.2013.11.008","article-title":"Hypo-glycosylated human follicle-stimulating hormone (hFSH(21\/18)) is much more active in vitro than fully-glycosylated hFSH (hFSH(24))","volume":"382","author":"Bousfield","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mce.2016.08.031","article-title":"Evaluation of in vivo bioactivities of recombinant hypo- (FSH(21\/18)) and fully- (FSH(24)) glycosylated human FSH glycoforms in Fshb null mice","volume":"437","author":"Wang","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib11","first-page":"885","article-title":"More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase","volume":"76","author":"Wide","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib12","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac161","article-title":"Follicle-stimulating hormone glycosylation variants distinctly modulate pre-antral follicle growth and survival","volume":"163","author":"Johnson","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib13","doi-asserted-by":"crossref","DOI":"10.1242\/dev.202170","article-title":"Oocyte quality is enhanced by hypoglycosylated FSH through increased cell-to-cell interaction during mouse follicle development","volume":"150","author":"Converse","year":"2023","journal-title":"Development"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/humrep\/dem305","article-title":"Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis","volume":"23","author":"Coomarasamy","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib15","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib16","first-page":"1","article-title":"The association between gonadotropin dosage and oocyte retrieval outcomes in in-vitro fertilization (IVF) cycles","volume":"9","author":"Enatsu","year":"2025","journal-title":"J Ob Gynecol Reprod Sci"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.fertnstert.2015.07.1151","article-title":"Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles","volume":"104","author":"Baker","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/biolre\/ioaa210","article-title":"Negative impact of high doses of follicle-stimulating hormone during superovulation on the ovulatory follicle function in small ovarian reserve dairy heifersdagger","volume":"104","author":"Karl","year":"2021","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fendo.2017.00114","article-title":"Efficacy of Follicle-Stimulating Hormone (FSH) alone, FSH + luteinizing hormone, human menopausal gonadotropin or FSH + human chorionic gonadotropin on assisted reproductive technology outcomes in the \"personalized\" medicine era: a meta-analysis","volume":"8","author":"Santi","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib20","article-title":"Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF\/ICSI cycles","volume":"5","author":"Mochtar","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046682","article-title":"LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling","volume":"7","author":"Casarini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41598-017-01078-8","article-title":"Human luteinizing hormone and chorionic gonadotropin display biased agonism at the LH and LH\/CG receptors","volume":"7","author":"Riccetti","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/biolre\/ioaf287","article-title":"The FSH\/FSHR axis in reproductive biology and oncogenesis: mechanisms and emerging targeted therapies","volume":"114","author":"Wang","year":"2026","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3892\/etm.2014.1683","article-title":"Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF\/ICSI: a meta-analysis","volume":"8","author":"Luo","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.fertnstert.2024.10.040","article-title":"The role of letrozole in in vitro fertilization treatment: new remedy or old mirage?","volume":"123","author":"Bulow","year":"2025","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2292612","article-title":"The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis","volume":"35","author":"Wu","year":"2024","journal-title":"Platelets"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/jcm15020410","article-title":"Letrozole Co-Administration in Progestin-Primed Ovarian Stimulation (PPOS) protocols for patients undergoing in vitro fertilization: a systematic review","volume":"15","author":"Di Girolamo","year":"2026","journal-title":"J Clin Med"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib28","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humrep\/deab249","article-title":"Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial","volume":"37","author":"Bulow","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","article-title":"A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders","volume":"102","author":"Yeung","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rbmo.2021.12.006","article-title":"Co-treatment with letrozole during ovarian stimulation for IVF\/ICSI: a systematic review and meta-analysis","volume":"44","author":"Bulow","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib33","article-title":"Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: a meta-analysis","volume":"50","author":"Qin","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00404-022-06676-0","article-title":"Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders","volume":"306","author":"Kahraman","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.fertnstert.2018.08.018","article-title":"Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes","volume":"110","author":"Regan","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1551126","article-title":"The role of growth hormone in assisted reproductive technology for patients with diminished ovarian reserve: from signaling pathways to clinical applications","volume":"16","author":"Han","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib37","article-title":"The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic review and meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib38","first-page":"CD009749","article-title":"Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction","volume":"2015","author":"Nagels","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.fertnstert.2020.03.007","article-title":"Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis","volume":"114","author":"Cozzolino","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib40","first-page":"CD000099","article-title":"Growth hormone for in vitro fertilisation (IVF)","volume":"11","author":"Sood","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/acel.12368","article-title":"Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging","volume":"14","author":"Ben-Meir","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12958-018-0343-0","article-title":"Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial","volume":"16","author":"Xu","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib43","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cub.2010.06.069","article-title":"Evidence that weakened centromere cohesion is a leading cause of age-related aneuploidy in oocytes","volume":"20","author":"Chiang","year":"2010","journal-title":"Curr Biol"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2026.1707614","article-title":"Preventing ovarian aging: from redox-targeted strategies to extracellular vesicle-based therapies","volume":"7","author":"Camerano Spelta Rapini","year":"2026","journal-title":"Front Aging"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.arthro.2011.10.018","article-title":"Platelet-rich plasma: a milieu of bioactive factors","volume":"28","author":"Boswell","year":"2012","journal-title":"Arthroscopy"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib46","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/humrep\/deab106","article-title":"Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?","volume":"36","author":"Atkinson","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/deae093","article-title":"Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trial","author":"Herlihy","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/humrep\/deae038","article-title":"Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial","volume":"39","author":"Barrenetxea","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.fertnstert.2025.05.143","article-title":"Impact of bilateral intraovarian platelet-rich plasma in women with poor ovarian response or primary ovarian insufficiency: a retrospective study","volume":"124","author":"Molinaro","year":"2025","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib50","first-page":"2099","article-title":"Platelet-rich plasma another add-on treatment getting out of hand? How can clinicians preserve the best interest of their patients?","volume":"34","author":"Urman","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib51","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2026.05.149_bib52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.rbmo.2020.08.035","article-title":"Effect of recombinant LH supplementation on cumulative live birth rate compared with FSH alone in poor ovarian responders: a large, real-world study","volume":"42","author":"Arvis","year":"2021","journal-title":"Reprod Biomed Online"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226004218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226004218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:39:13Z","timestamp":1793907553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028226004218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0015028226004218"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.05.149","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can a focus on intracellular signaling assist us with ovarian stimulation in poor-prognosis patients?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.05.149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92026 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}